{"denoms":[{"counts":[{"groupId":"BG000","value":"138"},{"groupId":"BG001","value":"135"},{"groupId":"BG002","value":"273"}],"units":"Participants"}],"groups":[{"description":"Induction therapy: Two 21-day cycles of chemotherapy consisting of docetaxel (75 mg/m2, day 1), cisplatin (75 mg/m2, day 1), and 5-fluorouracil (750 mg/m2/day, days 1-5). Total duration of 6 weeks.\n\nChemoradiotherapy: Five 14-day cycles of docetaxel (25 mg/m2, day 1), 5-fluorouracil (600 mg/m2/day, day 0-4), and hydroxyurea (500 mg PO q 12 hours x 6 days (11 doses)) with twice daily radiation (150 cGy given bid, days 1-5). Total duration of 10 weeks.\n\ndocetaxel: 75 mg/m2 on day 1 (induction phase); 25 mg/m2 on day 1 (chemoradiotherapy phase)\n\ncisplatin: 75 mg/m2 on day 1\n\nhydroxyurea: Each cycle: 500 mg PO q 12 hours x 6 days (11 doses)\n\nfluorouracil: 750 mg/m2/day on days 1-5 (induction phase); 600 mg/m2/day, day 0-4 (chemoradiotherapy phase)\n\nchemotherapy: See protocol for details\n\nradiotherapy: See protocol for details","id":"BG000","title":"Induction Plus Chemoradiotherapy"},{"description":"Chemoradiotherapy: Five 14-day cycles of docetaxel (25 mg/m2, day 1), 5-fluorouracil (600 mg/m2/day, day 0-4), and hydroxyurea (500 mg PO q 12 hours x 6 days (11 doses)) with twice daily radiation (150 cGy given bid, days 1-5). Total duration of 10 weeks.\n\ndocetaxel: 75 mg/m2 on day 1 (induction phase); 25 mg/m2 on day 1 (chemoradiotherapy phase)\n\nhydroxyurea: Each cycle: 500 mg PO q 12 hours x 6 days (11 doses)\n\nfluorouracil: 750 mg/m2/day on days 1-5 (induction phase); 600 mg/m2/day, day 0-4 (chemoradiotherapy phase)\n\nchemotherapy: See protocol for details\n\nradiotherapy: See protocol for details","id":"BG001","title":"Chemoradiotherapy"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"31","upperLimit":"75","value":"56.7"},{"groupId":"BG001","lowerLimit":"38","upperLimit":"82","value":"56.9"},{"groupId":"BG002","lowerLimit":"31","upperLimit":"82","value":"56.8"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"25"},{"groupId":"BG001","value":"17"},{"groupId":"BG002","value":"42"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"113"},{"groupId":"BG001","value":"118"},{"groupId":"BG002","value":"231"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"7"}]}],"title":"France"},{"categories":[{"measurements":[{"groupId":"BG000","value":"120"},{"groupId":"BG001","value":"123"},{"groupId":"BG002","value":"243"}]}],"title":"United States"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}]}],"title":"Spain"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"9"}]}],"title":"Croatia"},{"categories":[{"measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"13"}]}],"title":"Russia"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Region of Enrollment","unitOfMeasure":"Participants"}]}